Oncopeptides
Oncopeptides: First Licensing Deal (Redeye)
2024-09-12 14:50
Redeye comments on Oncopeptides’ licensing deal for Pepaxti in South Korea.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se